These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 401575)

  • 1. Fatal radiation pneumonia following subclinical busulfin injury.
    Soble AR; Perry H
    AJR Am J Roentgenol; 1977 Jan; 128(1):15-8. PubMed ID: 401575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Normal tissue tolerance to external beam radiation therapy: bone marrow].
    Drouet F; Lagrange JL
    Cancer Radiother; 2010 Jul; 14(4-5):392-404. PubMed ID: 20598617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
    Mundt AJ; Sibley G; Williams S; Hallahan D; Nautiyal J; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):261-70. PubMed ID: 7673013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute leukemia as terminal stage of Hodgkin's disease (author's transl)].
    Ehler R; Meyer P; Hartwich G
    Med Klin; 1976 Oct; 71(41):1740-3. PubMed ID: 979874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation following high-dose busulfan and VP-16 for advanced non-Hodgkin's lymphoma and Hodgkin's disease.
    Rosenfeld CS; Przepiorka D; Schwinghammer TL; Buck DS; Bloom EJ; Shadduck RK
    Exp Hematol; 1991 Jun; 19(5):317-21. PubMed ID: 2026183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera.
    Pezzimenti JF; Kim HC; Lindenbaum J
    Cancer; 1976 Dec; 38(6):2242-6. PubMed ID: 1069602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma.
    Fried W; Kedo A; Barone J
    Cancer Res; 1977 Apr; 37(4):1205-9. PubMed ID: 321118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
    Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
    Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do cytostatics change the histopathology of leukemias?].
    Rohmann I; Larrain C
    Rev Med Chil; 1971 Aug; 99(8):566-71. PubMed ID: 5571331
    [No Abstract]   [Full Text] [Related]  

  • 11. Late effects of radiation therapy in the treatment of Hodgkin's disease.
    Kinsella TJ; Fraass BA; Glatstein E
    Cancer Treat Rep; 1982 Apr; 66(4):991-1001. PubMed ID: 6804091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
    Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
    Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late complications after treatment of Hodgkin's disease].
    Lund MB; Kongerud J; Boe J; Ihlen H; Forfang K; Abrahamsen AF; Nome O
    Tidsskr Nor Laegeforen; 1999 Mar; 119(7):933-7. PubMed ID: 10210953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some factors in radiation-induced pulmonary changes after mantle field irradiation for Hodgkin's disease.
    Brouwers TM
    Neth J Med; 1976; 19(4-5):239-46. PubMed ID: 824560
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiation-induced lung injuries: a survey by computed tomography and pulmonary function tests in 18 cases of Hodgkin's disease.
    Frija J; Fermé C; Baud L; Gisselbrecht C; Miot C; Fermand JP; Laval-Jeantet M
    Eur J Radiol; 1988 Feb; 8(1):18-23. PubMed ID: 3356195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of radiation therapy and chemotherapy on testicular function.
    Kinsella TJ
    Prog Clin Biol Res; 1989; 302():157-71; discussion 172-7. PubMed ID: 2666987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy.
    Testa NG; Hendry JH; Molineux G
    Anticancer Res; 1985; 5(1):101-10. PubMed ID: 3888044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.
    Trump DL; Cowall DE
    Johns Hopkins Med J; 1977 Nov; 141(5):249-51. PubMed ID: 270597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute leukemia in the terminal phase of Hodgkin's disease: a consequence of the depressed immune function?].
    Tittor W; Drings P; Fritsch H
    Med Klin; 1975 Apr; 70(14):607-12. PubMed ID: 1097875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study.
    Kalifa C; Hartmann O; Demeocq F; Vassal G; Couanet D; Terrier-Lacombe MJ; Valteau D; Brugieres L; Lemerle J
    Bone Marrow Transplant; 1992 Apr; 9(4):227-33. PubMed ID: 1534708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.